{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T08:01:41Z","timestamp":1781078501920,"version":"3.54.1"},"reference-count":22,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinical-breast-cancer.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Breast Cancer"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.clbc.2025.08.002","type":"journal-article","created":{"date-parts":[[2025,8,10]],"date-time":"2025-08-10T14:18:38Z","timestamp":1754835518000},"page":"306-314","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Trajectory of Chemotherapy-Induced Peripheral Neuropathy and Its Predictive Factors in Breast Cancer Patients: A Prospective Longitudinal Study"],"prefix":"10.1016","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-4097-3451","authenticated-orcid":false,"given":"Huiqian","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yijing","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shufang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lizhi","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinghua","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1130","key":"10.1016\/j.clbc.2025.08.002_bib0001","doi-asserted-by":"crossref","DOI":"10.1259\/bjr.20211033","article-title":"Understanding breast cancer as a global health concern","volume":"95","author":"Wilkinson","year":"2022","journal-title":"Br J Radiol"},{"issue":"6","key":"10.1016\/j.clbc.2025.08.002_bib0002","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1177\/10547738221085613","article-title":"Severity, risk factors and quality of life of patients associated with chemotherapy-induced peripheral neuropathy","volume":"31","author":"Srivastava","year":"2022","journal-title":"Clin Nurs Res"},{"key":"10.1016\/j.clbc.2025.08.002_bib0003","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2019.102831","article-title":"Prevention of chemotherapy-induced peripheral neuropathy: a review of recent findings","volume":"145","author":"Ibrahim","year":"2020","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.clbc.2025.08.002_bib0004","doi-asserted-by":"crossref","unstructured":"Lee KT, Bulls HW, Hoogland AI, James BW, Colon-Echevarria CB, Jim HSL. Chemotherapy-induced peripheral neuropathy (CIPN): a narrative review and proposed theoretical model. Cancers. 2024;16(14):2571. doi: 10.3390\/cancers16142571.","DOI":"10.3390\/cancers16142571"},{"key":"10.1016\/j.clbc.2025.08.002_bib0005","doi-asserted-by":"crossref","unstructured":"M\u00fcller J, Kreutz C, Ringhof S, et al. Chemotherapy-induced peripheral neuropathy: longitudinal analysis of predictors for postural control. Sci Rep. 2021;11(1):2398. doi: 10.1038\/s41598-021-81902-4.","DOI":"10.1038\/s41598-021-81902-4"},{"issue":"4","key":"10.1016\/j.clbc.2025.08.002_bib0006","doi-asserted-by":"crossref","first-page":"E10","DOI":"10.1097\/NCC.0b013e31820251de","article-title":"Development and psychometric evaluation of the chemotherapy-induced peripheral neuropathy assessment tool","volume":"34","author":"Tofthagen","year":"2011","journal-title":"Cancer Nurs."},{"issue":"5","key":"10.1016\/j.clbc.2025.08.002_bib0007","first-page":"14","article-title":"Sinicization and reliability\/validity testing of assessment tools for chemotherapy-induced peripheral neuropathy","volume":"35","author":"Wang","year":"2018","journal-title":"J Nurs Sci PLA (Jiefangjun Huli Zazhi)"},{"issue":"2","key":"10.1016\/j.clbc.2025.08.002_bib0008","first-page":"98","article-title":"Theoretical basis and application of the Social Support Rating Scale (SSRS)","author":"Xiao","year":"1994","journal-title":"J Clin Psychiatry (Linchuang Jingshen Yixue Zazhi)"},{"issue":"6","key":"10.1016\/j.clbc.2025.08.002_bib0009","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/j.1600-0447.1983.tb09716.x","article-title":"The hospital anxiety and depression scale","volume":"67","author":"Zigmond","year":"1983","journal-title":"Acta Psychiatr Scand"},{"key":"10.1016\/j.clbc.2025.08.002_bib0010","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1186\/1471-2466-14-158","article-title":"Indacaterol improves lung hyperinflation and physical activity in patients with moderate chronic obstructive pulmonary disease\u2013a randomized, multicenter, double-blind, placebo-controlled study","volume":"14","author":"Watz","year":"2014","journal-title":"BMC Pulm Med"},{"issue":"3","key":"10.1016\/j.clbc.2025.08.002_bib0011","first-page":"286","article-title":"Development and psychometric evaluation of the Chinese version of the Health-Promoting Lifestyle Profile II (HPLP-II)","volume":"20","author":"Cao","year":"2016","journal-title":"Chin J Dis Control Prev"},{"issue":"4","key":"10.1016\/j.clbc.2025.08.002_bib0012","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/S0261-5614(03)00098-0","article-title":"ESPEN guidelines for nutrition screening 2002","volume":"22","author":"Kondrup","year":"2003","journal-title":"Clin Nutr"},{"issue":"1","key":"10.1016\/j.clbc.2025.08.002_bib0013","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.ad.2019.05.009","article-title":"Using the Common Terminology Criteria for Adverse Events (CTCAE - Version 5.0) to Evaluate the Severity of Adverse Events of Anticancer Therapies","volume":"112","author":"Freites-Martinez","year":"2021","journal-title":"Actas Dermosifiliogr"},{"issue":"6","key":"10.1016\/j.clbc.2025.08.002_bib0014","first-page":"2959","article-title":"Chemotherapy-induced peripheral neuropathy in newly diagnosed breast cancer survivors treated with taxane: a prospective longitudinal study","volume":"29","author":"Wang","year":"2021","journal-title":"Supp Care Can"},{"key":"10.1016\/j.clbc.2025.08.002_bib0015","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2024.1327318","article-title":"Risk factors of paclitaxel-induced peripheral neuropathy in patients with breast cancer: a prospective cohort study","volume":"14","author":"Lixian","year":"2024","journal-title":"Front Oncol"},{"issue":"2","key":"10.1016\/j.clbc.2025.08.002_bib0016","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s10549-016-3939-0","article-title":"Long-term chemotherapy-induced peripheral neuropathy among breast cancer survivors: prevalence, risk factors, and fall risk","volume":"159","author":"Bao","year":"2016","journal-title":"Breast Cancer Res Treat"},{"issue":"2","key":"10.1016\/j.clbc.2025.08.002_bib0017","doi-asserted-by":"crossref","first-page":"djw206","DOI":"10.1093\/jnci\/djw206","article-title":"Lifestyle factors and taxane-induced neuropathy in breast cancer patients: the pathways study","volume":"109","author":"Greenlee","year":"2016","journal-title":"J Natl Cancer Inst"},{"issue":"7","key":"10.1016\/j.clbc.2025.08.002_bib0018","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1093\/oncolo\/oyad062","article-title":"Patient characteristics associated with chemotherapy-induced peripheral neuropathy severity in a phase II clinical trial: a retrospective analysis","volume":"28","author":"Zhi","year":"2023","journal-title":"Oncologist"},{"issue":"7","key":"10.1016\/j.clbc.2025.08.002_bib0019","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0307865","article-title":"Correction: Risk factors and pharmacotherapy for chemotherapy-induced peripheral neuropathy in paclitaxel-treated female cancer survivors: a retrospective study in Japan","volume":"19","author":"Hiramoto","year":"2024","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.clbc.2025.08.002_bib0020","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1007\/s10549-020-05584-8","article-title":"Vitamin D deficiency increases severity of paclitaxel-induced peripheral neuropathy","volume":"180","author":"Jennaro","year":"2020","journal-title":"Breast Can Res Treat"},{"issue":"9","key":"10.1016\/j.clbc.2025.08.002_bib0021","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1001\/jamainternmed.2024.2354","article-title":"Preventive effect of neuromuscular training on chemotherapy-induced neuropathy: a randomized clinical trial","volume":"184","author":"Streckmann","year":"2024","journal-title":"JAMA Intern Med"},{"issue":"2","key":"10.1016\/j.clbc.2025.08.002_bib0022","doi-asserted-by":"crossref","first-page":"355","DOI":"10.3390\/jcm11020355","article-title":"A systematic review of nutritional lab correlates with chemotherapy induced peripheral neuropathy","volume":"11","author":"Tofthagen","year":"2022","journal-title":"J Clin Med"}],"container-title":["Clinical Breast Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526820925002290?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526820925002290?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T07:28:57Z","timestamp":1781076537000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1526820925002290"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S1526820925002290"],"URL":"https:\/\/doi.org\/10.1016\/j.clbc.2025.08.002","relation":{},"ISSN":["1526-8209"],"issn-type":[{"value":"1526-8209","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Trajectory of Chemotherapy-Induced Peripheral Neuropathy and Its Predictive Factors in Breast Cancer Patients: A Prospective Longitudinal Study","name":"articletitle","label":"Article Title"},{"value":"Clinical Breast Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clbc.2025.08.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}